Iodine Povacrylex Antisepsis Beneficial for Closed Extremity Fractures

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Feb. 1, 2024 -- For patients with closed extremity fractures, fewer surgical site infections occur with use of antisepsis with iodine povacrylex in alcohol, according to a study published in the Feb. 1 issue of the New England Journal of Medicine.

Sheila Sprague, Ph.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a cluster-randomized, crossover trial at 25 hospitals in the United States and Canada to compare use of alcohol solutions containing iodine povacrylex or chlorhexidine gluconate as skin antisepsis before surgery to repair a fractured limb. Hospitals were randomly assigned to use 0.7 percent iodine povacrylex in 74 percent isopropyl alcohol (iodine group) or 2 percent chlorhexidine gluconate in 70 percent isopropyl alcohol (chlorhexidine group) as preoperative antisepsis. The hospitals alternated interventions every two months. The trial included 6,785 patients with a closed fracture and 1,700 with an open fracture.

The researchers found that surgical-site infection occurred in 2.4 and 3.3 percent of patients in the iodine and chlorhexidine groups, respectively, in the closed-fracture population (odds ratio, 0.74; 95 percent confidence interval, 0.55 to 1.00; P = 0.049) and in 6.5 and 7.3 percent, respectively, in the open-fracture population (odds ratio, 0.86; 95 percent confidence interval, 0.58 to 1.27; P = 0.45). The two groups had similar frequencies of unplanned reoperation, one-year outcomes, and serious adverse events.

"The interventions that we compared in this trial are similar in price, availability, and directions for use," the authors write. "Our findings suggest that the use of iodine povacrylex in alcohol as preoperative skin antisepsis could prevent surgical-site infection in thousands of patients with closed fractures, but such use is unlikely to improve the outcomes in patients with open fractures."

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords